Please login to the form below

Not currently logged in
Email:
Password:

Tabalumab

This page shows the latest Tabalumab news and features for those working in and with pharma, biotech and healthcare.

Lilly reports first pivotal data for Xeljanz rival in arthritis

Lilly reports first pivotal data for Xeljanz rival in arthritis

Meanwhile, the positive data for baricitinib in RA is a boost for Lilly's anti-inflammatory portfolio, which suffered a casualty in October when tabalumab was dropped from development.

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics